Clevidipine for the Antihypertensive Treatment of Acute Intracerebral Hemorrhage
Sponsored by Zeenat Qureshi Stroke Institute
About this study
The aim is to compare the rate of hypertensive subjects with ICH who reach SBP target with stability within 60 minutes of enrollment, among patients treated with IV clevidipine with those treated with alternate IV antihypertensive regimen.
Enrolling at this location
Stanford Medical Center (Stanford Health Care)
Palo Alto, California
I'm interestedThis study also enrolls at 19 other locations. See all.
Completing a questionnaire on Clinably does not enroll you in a clinical trial or confirm your eligibility. Only the research team can determine whether you qualify to participate. These results are based on the information you provide and are intended to help you start a conversation with the research team.
Trial data sourced from ClinicalTrials.gov.